AIMS: To describe the IQED, a quality-assurance system started in 2001 in Belgian hospital-based multidisciplinary diabetes centres, and its effects on the quality of care. METHODS: The study was conducted through four data collections (in 2001, 2002, 2004 and 2006). Approximately 120 diabetes centres provided data on a systematic random sample of 10% of their adult diabetic patients on at least two daily insulin injections. Data on patient characteristics, glycaemic control, cardiovascular risk, diabetes complications, follow-up procedures and treatment were obtained. Local quality promotion was encouraged by returning comprehensive feedback (benchmarks) and during information meetings. RESULTS: Nearly all diabetes centres (98-100%) participated. The pooled sample consisted of 9194 (32%) Type 1 and 19 828 (68%) Type 2 diabetes patients, with mean diabetes duration of 17 years and 14 years, prevalence of microvascular complications of 23% and 38% and prevalence of macrovascular complications of 9% and 26%, respectively. At the start, the quality of care was good in terms of risk-factor testing rates and moderate in terms of patients meeting goals for risk-factor management. At least 50% of the centres initiated quality-promoting initiatives. After 5 years, significant improvements were seen in risk-factor testing rates, apart from renal screening. Improvements in intermediate outcomes were less obvious, apart from an increase in patients reaching the targets for blood pressure and LDL cholesterol. CONCLUSIONS: It is feasible to implement a continuous quality-improvement project on a nationwide scale, with improvements particularly in process indicators.
AIMS: To describe the IQED, a quality-assurance system started in 2001 in Belgian hospital-based multidisciplinary diabetes centres, and its effects on the quality of care. METHODS: The study was conducted through four data collections (in 2001, 2002, 2004 and 2006). Approximately 120 diabetes centres provided data on a systematic random sample of 10% of their adult diabeticpatients on at least two daily insulin injections. Data on patient characteristics, glycaemic control, cardiovascular risk, diabetes complications, follow-up procedures and treatment were obtained. Local quality promotion was encouraged by returning comprehensive feedback (benchmarks) and during information meetings. RESULTS: Nearly all diabetes centres (98-100%) participated. The pooled sample consisted of 9194 (32%) Type 1 and 19 828 (68%) Type 2 diabetespatients, with mean diabetes duration of 17 years and 14 years, prevalence of microvascular complications of 23% and 38% and prevalence of macrovascular complications of 9% and 26%, respectively. At the start, the quality of care was good in terms of risk-factor testing rates and moderate in terms of patients meeting goals for risk-factor management. At least 50% of the centres initiated quality-promoting initiatives. After 5 years, significant improvements were seen in risk-factor testing rates, apart from renal screening. Improvements in intermediate outcomes were less obvious, apart from an increase in patients reaching the targets for blood pressure and LDL cholesterol. CONCLUSIONS: It is feasible to implement a continuous quality-improvement project on a nationwide scale, with improvements particularly in process indicators.
Authors: K Doggen; N Debacker; D Beckers; K Casteels; M Coeckelberghs; L Dooms; H Dorchy; M Lebrethon; K Logghe; M Maes; G Massa; T Mouraux; R Rooman; G Thiry-Counson; S Van Aken; J Vanbesien; V Van Casteren Journal: Eur J Pediatr Date: 2012-08-09 Impact factor: 3.183
Authors: Patricia Sunaert; Hilde Bastiaens; Frank Nobels; Luc Feyen; Geert Verbeke; Etienne Vermeire; Jan De Maeseneer; Sara Willems; An De Sutter Journal: BMC Health Serv Res Date: 2010-07-14 Impact factor: 2.655
Authors: Frank Nobels; Noëmi Debacker; Carlos Brotons; Moses Elisaf; Michel P Hermans; Georges Michel; Erik Muls Journal: Cardiovasc Diabetol Date: 2011-09-22 Impact factor: 9.951
Authors: Viviane F A Van Casteren; Nathalie H E Bossuyt; Sarah J S Moreels; Geert Goderis; Katrien Vanthomme; Johan Wens; Etienne W De Clercq Journal: Arch Public Health Date: 2015-07-13
Authors: Patricia Sunaert; Sara Willems; Luc Feyen; Hilde Bastiaens; Jan De Maeseneer; Lut Jenkins; Frank Nobels; Emmanuel Samyn; Marie Vandekerckhove; Johan Wens; An De Sutter Journal: BMC Fam Pract Date: 2014-08-21 Impact factor: 2.497
Authors: Astrid Lavens; Kris Doggen; Chantal Mathieu; Frank Nobels; Evy Vandemeulebroucke; Michel Vandenbroucke; Ann Verhaegen; Viviane Van Casteren Journal: BMC Health Serv Res Date: 2016-08-23 Impact factor: 2.655
Authors: Patricia Sunaert; Hilde Bastiaens; Luc Feyen; Boris Snauwaert; Frank Nobels; Johan Wens; Etienne Vermeire; Paul Van Royen; Jan De Maeseneer; An De Sutter; Sara Willems Journal: BMC Health Serv Res Date: 2009-08-23 Impact factor: 2.655